Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Invesco Preferred ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Invesco Preferred ETF trades at $9.93 (market cap $3.61B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.6× Invesco Preferred ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Invesco Preferred ETF pays none. Which is the better fit depends on your goals.
| GEHC | PGX | |
|---|---|---|
Market Cap | $30.93B | $3.61B |
Volume | 5,033,451 | 11,813,431 |
Sector | Health | — |
52-Week High | $88.16 | $11.61 |
52-Week Low | $59.48 | $9.95 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 96 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
PGX trades at $10.04 with a modest 0.9% daily gain, but technical indicators signal a bearish trend with moving averages and oscillators pointing downward. The stock shows oversold conditions with RSI readings below 30, while support and resistance levels cluster tightly around $10. Recent corporate actions include dividend payments scheduled for 2026, though current financial ratios remain undisclosed.
The outlook for PGX appears cautious given the bearish technical momentum and lack of current fundamental data. Investment opportunity hinges on future earnings visibility and margin improvement, while risks include sustained selling pressure and potential competitive challenges in the preferred ETF space highlighted by recent media coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
